CPM
LEGN icon

Connective Portfolio Management’s Legend Biotech LEGN Stock Holding History

Connective Portfolio Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,500
Closed -$272K – 36
2025
Q4 		$272K Sell
12,500
-12,000
-49% -$344K 0.49% 37
2025
Q3 		$805K Buy
+24,500
New +$905K 1.42% 27

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Connective Portfolio Management's LEGN Position: Q1 2026 in Review

Connective Portfolio Management sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 12,500 shares — an estimated $272K sold.

Connective Portfolio Management first reported a position in LEGN in Q3 2025 and held it in 2 quarters. The position peaked at $805K in Q3 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Connective Portfolio Management reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Connective Portfolio Management sold 12,500 Legend Biotech shares in Q1 2026, an estimated $272K.
  • Connective Portfolio Management first reported a position in Legend Biotech in Q3 2025 and held it in 2 quarters.
  • Connective Portfolio Management's Legend Biotech position peaked at $805K in Q3 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Connective Portfolio Management's 13F filing for Q1 2026, filed 16 Apr 2026.